Ligand · V9V
V9V · N-(5-{3-[(1S,7R,8R,9S)-4-amino-2-oxo-7lambda~4~-thia-3, 5-diazatetracyclo[4.3.0.0~1,7~.0~7,9~]nona-3,5-dien-8-yl]propyl}thiophene-2-carbonyl)-L-glutamic acid
V9V, N-(5-{3-[(1S,7R,8R,9S)-4-amino-2-oxo-7lambda~4~-thia-3, 5-diazatetracyclo[4.3.0.0~1,7~.0~7,9~]nona-3,5-dien-8-yl]propyl}thiophene-2-carbonyl)-L-glutamic acid, in the MolNFT structures on GenesisL1: bound in 1 record (1 PDB entry).…
- Component
- V9V
- Class
- ligand
- Structures
- 1
- PDB entries
- 1
Binding sites
V9V in 1 structure; the first of them:
- 7JG4 · Human gar transformylase in complex with gar substrate and AGF131 inhibitor · V9V A1102 · binds ARG871, LEU892, PHE895, MET896, ARG897, ILE898, LEU899, VAL904 and 8 more
Residues it binds most
VAL 1, ARG 1, LEU 1, ALA 1, ASN 1, ASP 1, GLU 1, GLY 1, HIS 1, ILE 1 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.